Q32 Bio Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QTTB research report →
Companywww.q32bio.com
Q32 Bio Inc. , a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction in the United States. Its lead product candidate is ADX-097, a humanized anti-C3d monoclonal antibody fusion protein to restore complement regulation, which has completed Phase I clinical trial for the treatment of renal and other complement-mediated diseases of high unmet need, including lupus nephritis, immunoglobulin A nephropathy, complement component 3 glomerulopathy, and anti-neutrophil cytoplasmic antibody-associated vasculitis.
- CEO
- Jodie Pope Morrison
- IPO
- 2018
- Employees
- 28
- HQ
- Waltham, MA, US
Price Chart
Valuation
- Market Cap
- $72.44M
- P/E
- 2.40
- P/S
- 1.35
- P/B
- 1.73
- EV/EBITDA
- 1.48
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 99.50%
- Op Margin
- 39.84%
- Net Margin
- 61.86%
- ROE
- 230.68%
- ROIC
- 36.14%
Growth & Income
- Revenue
- $53.74M · 0.00%
- Net Income
- $29.82M · 162.47%
- EPS
- $2.42 · 147.27%
- Op Income
- $16.90M
- FCF YoY
- 50.52%
Performance & Tape
- 52W High
- $8.04
- 52W Low
- $1.34
- 50D MA
- $6.05
- 200D MA
- $3.71
- Beta
- -1.27
- Avg Volume
- 305.93K
Get TickerSpark's AI analysis on QTTB
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 24, 26 | Violette Shelia M. | other | 37,500 |
| Feb 24, 26 | Morrison Jodie Pope | other | 132,000 |
| Feb 24, 26 | Kalowski Lee | other | 53,250 |
| Feb 25, 26 | Kalowski Lee | sell | 3,995 |
| Feb 25, 26 | Morrison Jodie Pope | sell | 9,896 |
| Feb 25, 26 | Violette Shelia M. | sell | 2,815 |
| Jan 15, 26 | LAPORTE KATHLEEN | other | 23,272 |
| Jan 15, 26 | GRAYZEL DAVID S. | other | 16,363 |
| Jan 15, 26 | Lundberg Sven Ante | other | 20,363 |
| Dec 2, 25 | Morrison Jodie Pope | sell | 22,506 |
Our QTTB Coverage
We haven't published any research on QTTB yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate QTTB Report →